Study programme
Classes
- General Biochemistry +1GAF141 | Faculty of Pharmacy in Hradec Králové
- Xenobiochemistry +1GAF237 | Faculty of Pharmacy in Hradec Králové
- Xenobiochemistry - Practical Training +3GAF267 | Faculty of Pharmacy in Hradec Králové
- Selected Chapters from General Biochemistry +1GDEXP04 | Faculty of Pharmacy in Hradec Králové
- The Defense of Doctoral Thesis +1GDEXPODP1 | Faculty of Pharmacy in Hradec Králové
- Xenobiochemistry and Patobiochemistry +1GDEXPSDZ1 | Faculty of Pharmacy in Hradec Králové
Publications
- Role of carbonyl reducing enzymes in the phase I biotransformation of the non-steroidal anti-inflammatory drug nabumetone in vitro2013 | Faculty of Pharmacy in Hradec Králové
- Efficient isolation of carbonyl-reducing enzymes using affinity approach with anticancer drug oracin as a specific ligand2013 | Faculty of Pharmacy in Hradec Králové
- S-Nitrosoglutathione covalently modifies cysteine residues of human carbonyl reductase 1 and affects its activity2013 | Faculty of Pharmacy in Hradec Králové
- Salicylanilide derivatives block Mycobacterium tuberculosis through inhibition of isocitrate lyase and methionine aminopeptidase2012 | Faculty of Pharmacy in Hradec Králové
- Human microsomal carbonyl reducing enzymes in the metabolism of xenobiotics: well-known and promising members of the SDR superfamily2012 | Faculty of Pharmacy in Hradec Králové
- Metabolism of drugs and other xenobiotics2011 | Faculty of Pharmacy in Hradec Králové
- Enzyme stereospecificity as a powerful tool in searching for new enzymes2010 | Central Library of Charles University
- Partial purification and characterization of new human membrane-bound carbonyl reductase playing a role in the deactivation of the anticancer drug oracin2009 | Central Library of Charles University
- Inactivation of the anticancer drugs doxorubicin and oracin by aldo-keto reductase (AKR) 1C32008 | Central Library of Charles University
- Aldo-keto reductases (AKR) from the AKR1C subfamily catalyze the carbonyl reduction of the novel anticancer drug oracin in man2007 | Publication without faculty affiliation
Loading network view...